Format

Send to

Choose Destination
J Obes. 2015;2015:953138. doi: 10.1155/2015/953138. Epub 2015 Sep 7.

Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.

Author information

1
Practice for General Medicine, Kurfürstendamm 157/158, 10709 Berlin, Germany.
2
Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia.
3
Analyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, Germany.
4
Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany.

Abstract

BACKGROUND:

Litramine (IQP-G-002AS) was shown to be effective and safe for weight loss in overweight and obese subjects. However, long-term effectiveness on maintenance of body weight loss has yet to be ascertained.

OBJECTIVE:

To assess effect of Litramine on maintenance of body weight loss.

METHODS:

A double-blind, randomised, placebo-controlled trial on overweight and obese patients was conducted over two sites in Germany for 24 weeks. Subjects with documented previous weight loss of 3% over the last 3-6 months were randomised to groups given either Litramine (3 g/day) or a matching placebo. Primary endpoints were difference of mean body weight (kg) between baseline and end of study and maintenance of initially lost body weight in verum group, where maintenance is defined as ≤1% weight gain.

RESULTS:

Subjects who were taking Litramine lost significantly more body weight compared to the subjects taking placebo who gained weight instead (-0.62 ± 1.55 kg versus 1.62 ± 1.48 kg, p < 0.001). More importantly, 92% of subjects in Litramine group were able to maintain their body weight after initial weight loss, versus 25% in placebo group. No serious adverse events were reported throughout.

CONCLUSION:

Litramine is effective and safe for long-term body weight maintenance. Trial Registration. This trial is registered with Clinicaltrials.gov identifier: NCT01505387.

PMID:
26435849
PMCID:
PMC4576018
DOI:
10.1155/2015/953138
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center